Seven Mile Advisory’s Novo Nordisk NVO Stock Holding History

Seven Mile Advisory’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206K	Buy	+4,295	New	+$185K	0.14%	144
2025 Q4	–	Sell	-5,245	Closed	-$291K	–	301
2025 Q3	$291K	Sell	5,245 -1,374	-21%	-$80.4K	0.05%	209
2025 Q2	$457K	Buy	6,619 +545	+9%	+$37.1K	0.27%	68
2025 Q1	$422K	Sell	6,074 -504	-8%	-$41.6K	0.28%	72
2024 Q4	$566K	Sell	6,578 -843	-11%	-$91.2K	0.36%	51
2024 Q3	$884K	Buy	7,421 +303	+4%	+$40.4K	0.58%	31
2024 Q2	$1.02M	Sell	7,118 -25	-0.3%	-$3.31K	0.75%	23
2024 Q1	$917K	Buy	7,143 +273	+4%	+$32.5K	0.7%	26
2023 Q4	$711K	Buy	6,870 +202	+3%	+$20K	0.62%	31
2023 Q3	$606K	Buy	6,668 +718	+12%	+$63.2K	0.64%	33
2023 Q2	$481K	Buy	+5,950	New	+$486K	0.56%	43

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Seven Mile Advisory's NVO Position: Q2 2026 in Review

Seven Mile Advisory opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,295 shares worth $206K. The stake represents 0.14% of the portfolio and ranks #144 among its holdings. This is a return to the name: Seven Mile Advisory previously reported a position in NVO as recently as Q3 2025.

Seven Mile Advisory first reported a position in NVO in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.02M in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Seven Mile Advisory held 4,295 shares of Novo Nordisk worth $206K as of Q2 2026.
Novo Nordisk was a new Seven Mile Advisory position in Q2 2026.
Novo Nordisk made up 0.14% of Seven Mile Advisory's portfolio in Q2 2026, its #144 holding.
Seven Mile Advisory first reported a position in Novo Nordisk in Q2 2023 and has held it in 11 quarters since.
Seven Mile Advisory's Novo Nordisk position peaked at $1.02M in Q2 2024.
1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.